It goes without saying that when outsourcing clinical trials, the partnership between Sponsor and CRO is absolutely vital to the success of the study. Whilst never easy, it can be particularly difficult for smaller pharma companies and biotechs to establish a successful relationship with the big CROs, both in the short and long term for various reasons. To combat these challenges, a number of CROs have recently made significant efforts, launching specific biotech divisions.
Over the following pages, we explore the key aspects for both biotechs and CROs to consider when selecting partners and then building and maintaining a successful relationship.
